GE HealthCare Technologies Inc. which can be found using ticker (GEHC) now have 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $105.00 and $86.00 calculating the average target share price we see $92.74. (at the time of writing). Now with the previous closing price of $79.17 and the analysts are correct then there would likely be a percentage uptick in value of 17.1%. Also worth taking note is the 50 day moving average now sits at $80.67 and the 200 day MA is $77.18. The market cap for the company is 35.99B. The stock price for the company is currently $78.85 USD
The potential market cap would be $42,161,457,985 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 22.92, revenue per share of $42.80 and a 5.63% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
